Physician profile
Brian Spencer
NPI 1861965394
$1,769.11
in general payments reported to CMS, 2019-2025
7 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $820 · 2020: $21.99 · 2021: $77.63 · 2022: $37.28 · 2023: $59.12 · 2024: $621 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411 · Travel and Lodging: $294 · Gift: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.71 |
| Travel and Lodging | $294.19 |
| Gift | $107.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| American Orthodontics Corporation | $993.39 | 2019-2025 | Master Series, LP and Ifit Tubes, Radiance |
| Align Technology, INC. | $573.91 | 2021-2025 | Invisalign |
| 3m Company | $110.39 | 2020-2022 | |
| Premier Dental Products Company | $49.41 | 2023 | Enamel Pro Prophy Paste, Enamel Pro Varnish |
| Solventum Corporation | $17.72 | 2025 | 3m |
| Ormco Corporation | $14.58 | 2022 | |
| Voco America INC. | $9.71 | 2023 | Bifix Qm, Futurabond U, Admira Fusion X-Tra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Spencer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.